Biosynex (ALBIO) — Financial Flexibility Index
Biosynex (ALBIO) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of €-5.49 Million (operating CF €-7.07 Million minus capex €1.58 Million) represents 0% of total liabilities (€105.13 Million). Check ALBIO cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosynex Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Biosynex across 12 annual periods. For the full cash flow conversion analysis, see ALBIO cash flow conversion.
Annual Financial Flexibility Index for Biosynex (2008–2024)
Year-by-year free cash flow to debt coverage for Biosynex. Explore ALBIO debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | €-5.28 Million | €-10.12 Million | €114.19 Million | ▼ -118.2% |
| 2023 | 0.25x | €29.89 Million | €-9.65 Million | €117.41 Million | ▼ -32.3% |
| 2022 | 0.38x | €35.03 Million | €4.95 Million | €93.21 Million | ▼ -70.5% |
| 2021 | 1.27x | €128.85 Million | €109.83 Million | €101.14 Million | ▲ +86.9% |
| 2020 | 0.68x | €40.75 Million | €31.64 Million | €59.78 Million | ▲ +13.2% |
| 2019 | 0.60x | €10.22 Million | €1.10 Million | €16.97 Million | ▼ -35.9% |
| 2018 | 0.94x | €9.58 Million | €467.12K | €10.20 Million | ▲ +13.6% |
| 2017 | 0.83x | €9.60 Million | €484.82K | €11.60 Million | ▲ +2458.3% |
| 2016 | 0.03x | €489.91K | €489.91K | €15.15 Million | ▼ -52.2% |
| 2015 | 0.07x | €461.66K | €461.66K | €6.82 Million | ▼ -45.2% |
| 2009 | 0.12x | €119.33K | €72.40K | €965.95K | ▲ +156.0% |
| 2008 | -0.22x | €-161.13K | €-184.44K | €731.01K | — |